FundedIQ
Biotechnology

GEM: Funding, Investors & Team (Sep 2026)

GEM is one chewable bite of daily nutrition. Designed for humankind and backed by science, GEM deliciously features 13 whole plant ingredients that deliver more than 15 key vitamins, minerals, and herbs. No fillers or preservatives, just complementary nutrients that are easier to absorb, and easier on the planet. Founded in 2018, GEM is based in Venice, California.

www.dailygem.co LinkedIn Venice, United States 11-50 employees
Dietary Supplements Life Science Nutrition Organic Food
Total raised
$10.5M
Rounds
1
Latest
Undisclosed round
May 2021

GEM has raised $10.5M across 1 funding round on record, the most recent an undisclosed round of $10.5M announced in May 2021.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

GEM Company Profile and Key Stats

Total funding raised
$10.5M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$10.5M in May 2021
Employees
11-50
reported band
Headquarters
Venice, United States

Latest funding round on record: May 2021.

GEM Funding Rounds

Date
Round
Amount
Undisclosed round
$10.5M

GEM Founders and Leadership Team

Name
Role
Contact
Sara Cullen
CEO
Locked

Contact details for the GEM team: 1 of 1 has an email address on file.

Start 14-day free trial →

GEM Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

GEM's latest round of $10.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like GEM in Biotechnology and Venice

Companies Similar to GEM

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

GEM Funding FAQs

What does GEM do?

GEM is one chewable bite of daily nutrition. Designed for humankind and backed by science, GEM deliciously features 13 whole plant ingredients that deliver more than 15 key vitamins, minerals, and herbs. No fillers or preservatives, just complementary nutrients that are easier to absorb, and easier on the planet. Founded in 2018, GEM is based in Venice, California.

How much funding has GEM raised?

GEM has raised $10.5M across 1 round on record. The most recent is an undisclosed round of $10.5M announced in May 2021.

When did GEM last raise funding?

GEM's most recent funding round on record is an undisclosed round of $10.5M, announced in May 2021.

Who is the CEO of GEM?

Sara Cullen is listed as CEO at GEM.

Where is GEM headquartered?

GEM is based in Venice, California, United States.

How many employees does GEM have?

GEM is in the 11-50 employee band.

How does GEM's funding compare to other Biotechnology startups?

GEM's latest round of $10.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's GEM Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for GEM is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.